SAI Parenterals Limited (SPL), an India-based pharmaceutical formulation company, has announced the acquisition of a 74....
Beyond tariff cuts, FTAs deliver deep structural benefits through regulatory alignment and facilitation of trade. Firms ...
In both the US and Japan, regulators provide an extensive set of resources detailing the rules and specifications govern...
In today’s global, multi-provider clinical trial environment, sponsors need to rapidly and accurately assess vast ...
In 2026, oncology drug development in Asia may move away from the historical maximum tolerated dose (MTD) paradigm towar...
2025 was the year when China’s stratospheric rise on the global biotech stage continued. According to a report fro...
The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spin...
Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has signed an exclusive licensing agreement wi...
Jyong Biotech, a science-driven biotechnology company based in Taiwan committed to developing and commercialising innova...
Singapore headquartered Prestige Biopharma, a biopharmaceutical company specialising in antibody therapeutics, has annou...
Algorithm, a pioneering regional pharmaceutical manufacturer has announced the signing of a strategic partnership agreem...
When Najat Khan steps into her new role as CEO and President of Recursion, she inherits more than a celebrated...
Coverage Report by Hithaishi Bhaskar The 93rd API China, held from November 12 to 14, 2025, at...
Coverage Report by Hithaishi Bhaskar The 93rd API China, China’s first and longest-running pharmaceutical ingredi...
Australia's Telix Pharmaceuticals has announced the official opening of Telix Manufacturing Solutions (TMS) in Yoko...
Japan-headquartered Nxera Pharma has announced a focused restructuring designed to concentrate investment and resources ...
Global biopharma leader CSL has announced plans to expand its US presence over the next five years, resulting in approxi...
As a key step in Bayer’s “In China, for Global” strategy, the Bayer E-Town Open Innovation Center offi...
South Korea-based ABL Bio, a company specializing in bispecific antibodies, has entered license, research and collaborat...
Anand Shetty, Corporate Vice President, Southeast Asia, Novo Nordisk (left) Dr Abel Soh, Consultant Endocrinologist f...
Puerto Rico’s transformation into a powerhouse of advanced biopharmaceutical manufacturing is gaining new momentum...
Japan's Meiji Seika Pharma has decided to establish a local subsidiary in Singapore to strengthen its presence and exp...
Taiwan-based EirGenix Inc. has entered into a second global exclusive licensing agreement with international biosimilar ...
Kaigene Inc., a US-based biotechnology startup pioneering next-generation antibody therapeutics for autoimmune disorders...
Boehringer Ingelheim, one of the world’s leading research-driven pharmaceutical companies, has announced that the&...
